Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martinez

Showing results (371-380 of 600) with videos related to

Pageof 60
Sort By:
Journal of Virology|December 24, 2010
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllersFrancois Vigneault, Matthew Woods, Maria J Buzon, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2020
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agentJosé Moltó, Miriam Rosás-Umbert, Cristina Miranda, et al.
Journal of Abdominal Wall Surgery : JAWS|February 5, 2024
Incisions in Hepatobiliopancreatic Surgery: Surgical Anatomy and its Influence to Open and Close the AbdomenManuel Medina Pedrique, Álvaro Robin Valle de Lersundi, Adriana Avilés Oliveros, et al.
Journal of Clinical Medicine|December 7, 2019
Enhancement of Antiviral CD8<sup>+</sup> T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with PembrolizumabOscar Blanch-Lombarte, Cristina Gálvez, Boris Revollo, et al.
Molecular Aspects of Medicine|August 18, 2022
Role of Siglecs in viral infections: A double-edged sword interactionDàlia Raïch-Regué, Patricia Resa-Infante, Marçal Gallemí, et al.
Frontiers in Immunology|February 7, 2019
Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated CellsAlba Ruiz, Oscar Blanch-Lombarte, Esther Jimenez-Moyano, et al.
Viruses|June 2, 2021
Phylogenetic Analysis of the 2020 West Nile Virus (WNV) Outbreak in Andalusia (Spain)Carlos S Casimiro-Soriguer, Javier Perez-Florido, Jose L Fernandez-Rueda, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
Journal for Immunotherapy of Cancer|November 7, 2023
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancerThomas A Odeny, Kathryn Lurain, Julius Strauss, et al.
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
Pageof 60

Showing results (371-380 of 600) with videos related to

Sort By:
Pageof 60
Journal of Virology|December 24, 2010
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllersFrancois Vigneault, Matthew Woods, Maria J Buzon, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2020
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agentJosé Moltó, Miriam Rosás-Umbert, Cristina Miranda, et al.
Journal of Abdominal Wall Surgery : JAWS|February 5, 2024
Incisions in Hepatobiliopancreatic Surgery: Surgical Anatomy and its Influence to Open and Close the AbdomenManuel Medina Pedrique, Álvaro Robin Valle de Lersundi, Adriana Avilés Oliveros, et al.
Journal of Clinical Medicine|December 7, 2019
Enhancement of Antiviral CD8<sup>+</sup> T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with PembrolizumabOscar Blanch-Lombarte, Cristina Gálvez, Boris Revollo, et al.
Molecular Aspects of Medicine|August 18, 2022
Role of Siglecs in viral infections: A double-edged sword interactionDàlia Raïch-Regué, Patricia Resa-Infante, Marçal Gallemí, et al.
Frontiers in Immunology|February 7, 2019
Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated CellsAlba Ruiz, Oscar Blanch-Lombarte, Esther Jimenez-Moyano, et al.
Viruses|June 2, 2021
Phylogenetic Analysis of the 2020 West Nile Virus (WNV) Outbreak in Andalusia (Spain)Carlos S Casimiro-Soriguer, Javier Perez-Florido, Jose L Fernandez-Rueda, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
Journal for Immunotherapy of Cancer|November 7, 2023
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancerThomas A Odeny, Kathryn Lurain, Julius Strauss, et al.
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
Pageof 60